Evidence map›Paper›PMID 35671428›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

WNT/RYK signaling functions as an antiinflammatory modulator in the lung mesenchyme.

Hyun-Taek Kim, Paolo Panza, Khrievono Kikhi, Yuko Nakamichi, Ann Atzberger, Stefan Guenther, Clemens Ruppert, Andreas Guenther, Didier Y R Stainier

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Analysis of MSX1, RYK, NFκB p65, and CCL4 Proteins andInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Hyun-Taek KimDepartment of Developmental Genetics, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.
Paolo PanzaDepartment of Developmental Genetics, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.ORCID 0000-0002-8702-5504
Khrievono KikhiFlow Cytometry Facility, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.ORCID 0000-0001-5672-3791
Yuko NakamichiInstitute for Oral Science, Matsumoto Dental University, 399-0781 Shiojiri, Japan.ORCID 0000-0001-9887-9903
Ann AtzbergerFlow Cytometry Facility, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.
Stefan GuentherCardiopulmonary Institute, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.
Clemens RuppertMember of the German Center for Lung Research, Partner Site Universities of Giessen and Marburg Lung Center, 35392 Giessen, Germany.ORCID 0000-0002-0938-2469
Andreas GuentherCardiopulmonary Institute, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.
Didier Y R StainierDepartment of Developmental Genetics, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany.ORCID 0000-0002-0382-0026
Max Planck Institute for Heart and Lung Research · DEGerman Center for Lung Research · DEMatsumoto Dental University · JPSoonchunhyang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of inflammatory lung diseases, including chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and pneumonia, are modulated by WNT/β-catenin signaling. However, the underlying molecular mechanisms remain unclear. Here, starting with a forward genetic screen in mouse, we identify the WNT coreceptor Related to receptor tyrosine kinase (RYK) acting in mesenchymal tissues as a cell survival and antiinflammatory modulator.

Indexed as

beta CateninPneumoniaReceptor Protein-Tyrosine KinasesWnt Signaling PathwayAnimalsHumansLungMesodermMiceNF-kappa BStromal Cellsbeta CateninNF-kappa BReceptor Protein-Tyrosine KinasesRYK protein, humanRyk protein, mouseinflammatory lung diseaselung mesenchymeWNT/RYK signaling

Identifiers

PMID35671428
PMCPMC9214544
OpenAlexW4281997744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.